Citadel Advisors - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$14,384,939
+16.5%
1,986,870
+19.6%
0.00%0.0%
Q2 2023$12,346,320
-34.1%
1,661,685
-38.5%
0.00%
-25.0%
Q1 2023$18,725,511
-46.5%
2,702,094
-20.6%
0.00%
-55.6%
Q4 2022$34,978,183
-32.2%
3,402,547
+20.0%
0.01%
-18.2%
Q3 2022$51,602,000
-72.7%
2,835,293
-22.9%
0.01%
-77.1%
Q2 2022$189,128,000
-22.0%
3,677,359
+11.7%
0.05%
-4.0%
Q1 2022$242,442,000
-43.3%
3,291,816
+10.1%
0.05%
-42.5%
Q4 2021$427,792,000
-16.1%
2,990,088
+21.6%
0.09%
-17.9%
Q3 2021$509,658,000
-12.3%
2,458,432
-10.2%
0.11%
-18.5%
Q2 2021$581,001,000
+50.1%
2,736,568
+28.2%
0.13%
+36.8%
Q1 2021$386,995,000
+52.7%
2,134,436
-6.1%
0.10%
+43.9%
Q4 2020$253,461,000
-4.3%
2,272,995
-7.0%
0.07%
-12.0%
Q3 2020$264,814,000
+132.8%
2,444,059
+79.1%
0.08%
+87.5%
Q2 2020$113,731,000
+2237.3%
1,364,508
+280.8%
0.04%
+1900.0%
Q1 2020$4,866,000
+1125.7%
358,333
+259.4%
0.00%
Q4 2019$397,000
-62.3%
99,700
-52.5%
0.00%
Q3 2019$1,053,000
+770.2%
209,815
+918.5%
0.00%
Q2 2019$121,00020,6000.00%
Other shareholders
NOVAVAX INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders